Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1636
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18594869 | CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) | Non-Final OA | DSM IP ASSETS B.V. |
| 17057863 | METHOD | Final Rejection | Oxford Nanopore Technologies PLC |
| 18544882 | METHODS FOR THE IDENTIFICATION OF VARIANT RECOGNITION SITES FOR RARE-CUTTING ENGINEERED DOUBLE-STRAND-BREAK-INDUCING AGENTS AND COMPOSITIONS AND USES THEREOF | Final Rejection | PIONEER HI-BRED INTERNATIONAL, INC. |
| 16984885 | COMPOSITIONS AND METHODS FOR IDENTIFYING A SINGLE-NUCLEOTIDE VARIANT | Final Rejection | President and Fellows of Harvard College |
| 17632263 | EXON 44-TARGETED NUCLEIC ACIDS AND RECOMBINANT ADENO-ASSOCIATED VIRUS COMPRISING SAID NUCLEIC ACIDS FOR TREATMENT OF DYSTROPHIN-BASED MYOPATHIES | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 17612245 | NON-CLASS I MULTI-COMPONENT NUCLEIC ACID TARGETING SYSTEMS | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18043792 | SYSTEMS AND METHODS FOR CONTROLLING BACTERIAL TRANSCRIPTION | Final Rejection | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 17770531 | A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY | Final Rejection | The Johns Hopkins University |
| 18495741 | SUGAR-CONJUGATED LIPID NANOPARTICLES AND METHODS OF USE THEREFOR | Non-Final OA | University of Virginia Patent Foundation |
| 18282421 | Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion | Non-Final OA | The General Hospital Corporation |
| 17084721 | TYPE V CRISPR-CAS BASE EDITORS AND METHODS OF USE THEREOF | Final Rejection | Pairwise Plants Services, Inc. |
| 17795191 | COMPOSITIONS FOR SMALL MOLECULE CONTROL OF PRECISE BASE EDITING OF TARGET NUCLEIC ACIDS AND METHODS OF USE THEREOF | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17603993 | COMPOSITIONS FOR REGULATING AND SELF-INACTIVATING ENZYME EXPRESSION AND METHODS FOR MODULATING OFF-TARGET ACTIVITY OF ENZYMES | Final Rejection | The Trustees of the University of Pennsylvania |
| 18053696 | METABOLIC ENGINEERING OF CUPRIAVIDUS NECATOR FOR IMPROVED FORMATE UTILIZATION | Final Rejection | Alliance for Energy Innovation, LLC |
| 18021450 | CONSTITUTIVELY ACTIVE TCF1 TO PROMOTE MEMORY-ASSOCIATED TRAITS IN CAR T CELLS | Non-Final OA | Seattle Children's Hospital (dba Seattle Children's Research Institute) |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy